EXTENSIVE STAGE SMALL CELL LUNG CANCER
Clinical trials for EXTENSIVE STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to slow advanced lung cancer
Disease control Recruiting nowThis study tests a new treatment plan for people with extensive stage small cell lung cancer who have not had treatment before. Participants first get standard chemo-immunotherapy, then a maintenance therapy with two drugs: durvalumab and ceralasertib. The goal is to see if this …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Muhammad Furqan • Aim: Disease control
Last updated May 01, 2026 15:26 UTC
-
New drug duo aims to control tough lung cancer
Disease control Recruiting nowThis early-stage study tests whether combining two drugs, valemetostat and atezolizumab, is safe for people with extensive-stage small cell lung cancer. About 24 adults will receive different doses of valemetostat alongside atezolizumab to find the best dose with the fewest side …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:26 UTC
-
New hope for aggressive lung cancer: experimental drug combo enters phase 3 trial
Disease control Recruiting nowThis study tests whether a new drug called BNT327, combined with standard chemotherapy, works better than the current standard treatment (atezolizumab plus chemo) for people with advanced small-cell lung cancer that has spread. About 621 participants will be randomly assigned to …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 01, 2026 15:25 UTC
-
New hope for aggressive lung cancer: drug cocktail shows promise in early trial
Disease control Recruiting nowThis study tests a new drug called ifinatamab deruxtecan (I-DXd) combined with standard treatments for people with extensive-stage small cell lung cancer (ES-SCLC), a fast-growing cancer that has spread widely. The goal is to see if this combination is safe and helps control the …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Triple threat: new combo aims to control aggressive lung cancer
Disease control Recruiting nowThis study tests a new first-line treatment for people with extensive-stage small-cell lung cancer, a fast-growing cancer that has spread. The treatment combines the immunotherapy drug tislelizumab with standard chemotherapy and radiation to the chest. The goal is to see if this …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Second Hospital of Shanxi Medical University • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Radiation boost may extend life in tough lung cancer
Disease control Recruiting nowThis study is for people with extensive-stage small cell lung cancer that hasn't been treated yet. Researchers want to see if adding focused radiation to the standard combination of durvalumab and chemotherapy can help control the cancer longer. About 49 participants will receive…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
Can your immune cells predict lung cancer treatment success?
Knowledge-focused Recruiting nowThis study looks at whether a special test (T cell repertoire technology) can predict how well a combination of the drug tislelizumab and standard chemotherapy works for people with extensive-stage small cell lung cancer. Researchers will follow 40 patients who have not yet been …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Sponsor: Henan Cancer Hospital • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC